Printer Friendly

Halifax portfolio firm Envision Pharma buys ProScribe.


6 February 2014 - US technology and scientific communication company Envision Pharma Group, backed by buyout firm The Halifax Group, said it had purchased Australian medical writing specialist ProScribe Medical Communications, without specifying the price.

ProScribe, which was founded by Karen Woolley and Mark Woolley, will become Envision Pharma's fifth division, named Scientific Solutions.

The target's founders will join the buyer's senior management and will continue to lead the ProScribe team, Envision Pharma said.

The deal expands Envision Pharma's footprint and capabilities within the strategically important Asia-Pacific region, enabling it to cater to a pharmaceutical and biotechnology sector that is global in nature, the buyer said.

ProScribe has locations in Australia, China and Japan and serves academia, biopharma and medical device firms.

Country: Australia

Sector: Business and Consumer Services, Media

Target: ProScribe Medical Communications

Buyer: The Halifax Group, Envision Pharma Group

Vendor: Mark Woolley, Karen Woolley

Type: Corporate acquisition, LBO

Status: Closed

COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Feb 6, 2014
Previous Article:Whitmore expands product offering with buy of Fluid Defense.
Next Article:Croatia to renew attempt to divest Croatia Airlines.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters